Skip to content
Clinical ResearchResearch compound

CJC‑1295 / Ipamorelin

Combination of two experimental peptides that raises growth hormone levels in two ways; only a few small human studies.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

CJC-1295 / Ipamorelin vial

DETAILED OVERVIEW

What is CJC-1295 / Ipamorelin?

CJC-1295 / ipamorelin is the combined use of two experimental peptides, short protein chains. CJC-1295 is a modified version of GHRH, the natural hormone that releases growth hormone (GH), and ipamorelin mimics a hormone called ghrelin. Both increase the release of GH in its natural, pulse-like pattern, but in different ways, through two different docking points on the cells (receptors).

The signals of the two substances reinforce each other. Ipamorelin is also selective: it stimulates growth hormone while the stress hormone cortisol and prolactin rise only minimally. The evidence comes from separate studies of the two substances, and only a few small studies have been done in humans so far.

Type

Two peptides: a growth hormone-releasing analog and a ghrelin mimic

Structure

CJC-1295 (30 aa) + Ipamorelin (5 aa)

Molecular weight

~3367 + ~712 Da

Target area

Pulsatile GH increase (IGF-1)

Storage

2–8°C (reconstituted)

Stability

25–30 days (reconstituted)

Growth hormone release

The peptide acts on pituitary GHRH or GHS receptors, producing a physiological, pulsatile GH release, unlike synthetic rHGH, which keeps levels flat and leads to desensitization. IGF-1 rises into the upper-normal range, driving recovery, muscle protein synthesis, lipolysis and skin quality. Deep-sleep phases lengthen; collagen and bone-matrix synthesis activate. The effect is reversible and does not suppress the endogenous GH axis.

Composition

This stack contains the following peptides

Data console

Lab data

ClassificationTwo peptides: a growth hormone-releasing analog and a ghrelin mimic
StructureCJC-1295 (30 aa) + Ipamorelin (5 aa)
Molecular weight~3367 + ~712 Da
Target areaPulsatile GH increase (IGF-1)
Storage2–8°C (reconstituted)
Stability25–30 days (reconstituted)

Research indications

Investigated uses and mechanisms

Growth hormone release

Mimics physiological pulsatile GH secretion; IGF-1 rise.

Recovery & body comp

Muscle mass gain, fat reduction, post-workout recovery.

Sleep quality

Deep-sleep (N3) phases lengthen.

Reconstitution

How to prepare, step by step

Important

Sterile technique required. Use bacteriostatic water (BAC) only. Never distilled or tap water.

  1. 01

    Remove the vial and bacteriostatic water (BAC) from refrigeration; let them reach room temp for 5 minutes.

  2. 02

    Wipe both vial stoppers with an alcohol swab.

  3. 03

    Draw 2 ml of BAC water into a sterile syringe (typical for the 5 mg vial).

  4. 04

    Inject slowly down the side of the vial, do NOT spray directly onto the peptide powder.

  5. 05

    Swirl gently in a circular motion until dissolved (~30 s), do not shake.

  6. 06

    Wait for the solution to become clear. If sediment or discoloration appears, discard it.

  7. 07

    Label the vial with reconstitution date and concentration.

  8. 08

    Store at 2–8 °C, protected from light. Inspect visually before each use.

Quality indicators

How to recognize a pure peptide

Purity markers

4
  • White / off-white powder

    Typical appearance of sterile lyophilized peptide.

  • Comes with COA (Certificate of Analysis)

    Independent lab analysis, ≥98% purity.

  • Intact, sealed vial

    Rubber stopper + aluminum crimp intact, ensuring sterility.

  • Dissolves clear

    Clear solution after reconstitution, no sediment.

Use caution

1
  • Storage temperature

    Extended room-temp exposure may reduce potency.

Do not use

2
  • Discoloration / sediment

    Yellow, cloudy or particulate solution, indicates degradation, do not use.

  • Damaged packaging

    Cracked vial or loose cap, sterility compromised, discard.

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Injection-site redness, itching
  • Water retention, mild edema
  • Wrist / joint stiffness (carpal-tunnel-like)
  • Transient blood-glucose increase
  • Mild prolactin / cortisol increase (some peptides)

Contraindications · 5

  • Pregnancy and breastfeeding
  • Active malignancy
  • Known allergy to the peptide or its components
  • Severe hepatic or renal impairment (medical consultation required)
  • Age under 18

Related Peptides

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about CJC‑1295 / Ipamorelin?

Reach out to an advisor on Telegram. We can help you find the right peptide.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.